The effectiveness of vaccination with whole-cell pertussis vaccine by age group in Poland 1996-2001

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 2, 2004, Pages 114-118

  Zieliński, Andrzej ^a   Rosińska, Magdalena ^a   Czarkowski, Miroslaw ^a   Rudowska, Jolanta ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BACTERIAL GENOME; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; HUMAN; HYPOTHESIS; IMMUNIZATION; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; POLAND; RECURRENT INFECTION; VACCINATION;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; INFANT; MALE; PERTUSSIS VACCINE; POLAND; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; VACCINATION; WHOOPING COUGH;

EID: 1542329768     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310018897     Document Type: Article

References (19)

1. CDC. Pertussis-United States, 1997-2000. MMWR 2002; 51(04): 73-6.
2. Skowronski DM, De Serres G, Macdonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Inf Dis 2002; 185: 1448-53.
3. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 y community study. Br Med J 1988; 296: 612-4.
4. Ramsay ME, Farrington CP, Miller E. Age specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect 1993; 111(1): 41-8.
5. Blakely TA, Mansoor O, Baker M. The 1996 pertussis epidemic in New Zeland: vaccine effectiveness. N Z Med J 1999; 112(1085): 118-20.
6. Torvaldsen S, Simpson JM, McIntyre P. Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998. Eur J Epid 2003; 18: 63-9.
7. Olin P, Gustafsson L, Barreto L, Hessel L, Mast TC, Rie AV, et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine 2003; 21(17-18): 20024-30.
8. van Loo IH, van der Heide HG, Nagelkerke NJ, Verhoef J, Mooi FR. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Inf Dis 1999; 179: 915-23.
9. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of The Netherlands: observations on surveillance data. Emerg Infect Dis 2000; 6: 348-57.
10. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/peractin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine driven evolution. Infect Immun 1998; 66: 670-5.
11. Chodorowska M, Kuklinska D. Restrictive analysis of DNA of Bordetella pertussis isolated from cases of pertussis in 1968 and in 1995-1998 and also from strains used for production of antipertussis vaccine used in Poland. Med Dos Mikrobiol 2000; 52: 111-7.
12. Gzyl A, Augustynowicz E, Ślusarczyk J. Sequence analysis of pertussis toxin and pertractin of Bordetella pertussis strains in context of effectiveness of anti-pertussis vaccinations. I Med J Exp Clin Res 2000; 6(Suppl 3): 114.
13. Gzyl A, Augustynowicz E, van Loo I, Slusarczyk J. Temporal nucleotide changes in peractin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 2001; 20: 299-303.
14. Zielinski A, Czarkowski MP. Effectiveness of vaccinations against pertussis at the time of the 1997-1998 epidemic. Polsce Przegl Epidemiol 2001; 55: 207-16.
15. Ślusarczyk J, Dulny G, Nowak K, Kryszyna J, Wysokinska T, Fordymacka A, et al. Immunity of children aged 6-8 against pertussis, tetanus and diphtheria. Przegl Epidemiol 2002; 56: 39-48.
16. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Epidemiol Rev 1988; 10: 212-41.
17. Cameron AC, Trived PK. Regression Analysis of Count Data. Cambridge, UK: Cambridge University Press; 1998.
18. Khattak MN, Mathews RC, Burnie JP. Is Bordetella pertussis clonal? Br Med J 1992; 304: 813-5.
19. Guiso N, Borsaux-Eude C, Weber C, Hausman SZ, Sato H, Iwaki M, et al. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. Vaccine 2001; 19: 3248-52.